08:44 AM EDT, 07/14/2021 (MT Newswires) -- Health Canada has issued to MediPharm Labs Corp. (LABS.TO), a cannabis extraction company, a Drug Establishment Licence in accordance with the Food and Drugs Act and Regulations, the company said Wednesday.
The company's shares edged up 1.1% in Canada yesterday.
The license allows the company to conduct pharmaceutical manufacturing and sell Active Pharmaceutical Ingredients and Pharmaceutical Drug Products. The Health Canada DEL can be recognized in more than 50 different countries, including the US and the majority of the European Union.
MediPharm Labs can now function as a full-service pharmaceutical company that can support the global pharma entry into the drugs containing cannabis market, including in the US.